Biologic Solutions for Chronic Wounds in Milwaukee, WI

How Milwaukee is not Florida First Coast

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. 14.1% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick biologic solutions chronic wounds against that mix.

Cash PRP and Medicare CTPs in the same hallway

• CDC PLACES (2023, crude) estimates 14.7% of adults in Milwaukee have diagnosed diabetes — 2.7 points above the U.S. 12% figure. Adult obesity in Milwaukee is 41.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails J6 review. Product is the last step, not the first.
• Wisconsin is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• Wisconsin public-health data live at Wisconsin Department of Health Services. Use those pages for community education; use FDA tissue-bank paperwork for the product in the fridge. Mixing the two is how practices get warning letters.

What CDC PLACES and J6 each actually tell you

J6 reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Milwaukee is 14.7% or not. PLACES is planning data. The LCD is the claim.

Before the first biologic solutions chronic wounds shipment